Sandra M Axiak-Bechtel, Stacey B Leach, Jessica R Newton-Northup, Rowan J Milner, Stacey A Fox-Alvarez, Lana I Fagman, Kaylee A Young, Deborah J Tate, Zachary M Wright, John D Chretin, Justin W Allen, Sean K Yoshimoto, Kimberly A Selting, Brian K Flesner, Carrie R White, Tracy Mills, Michael Aherne, Philip J Bergman, LeAnn Qi, Kenneth A Gruber, Michael F Callahan
BACKGROUND: The melanocortin 4 antagonist TCMCB07 is safe and effective in reversing cachexia caused by sepsis or cancer in rodents. The safety and pharmacokinetics of TCMCB07 are demonstrated in healthy beagle dogs. HYPOTHESIS/OBJECTIVES: The objectives of this study were to investigate the safety, peak plasma concentrations, and potential for efficacy of TCMCB07 in pet dogs with naturally occurring cachexia over a 4-week time period. ANIMALS: Fourteen dogs with cachexia of any underlying cause, except cancer of the oral cavity or gastrointestinal tract, were eligible for enrollment with informed client consent...
2023: Journal of Veterinary Internal Medicine